" 203.10 
restrictions on reimportation. 
no prescription drug or drug composed wholly or partly of insulin that was manufactured in a state and exported from the united states may be reimported by anyone other than its manufacturer, except that fda may grant permission to a person other than the manufacturer to reimport a prescription drug or insulin-containing drug if it determines that such reimportation is required for emergency medical care.", 
